Clinical Trial Update: Biomarker-Integrated Digital Guidance for Early Alzheimer's Detection (BRIDGE-AD): A Nationwide Multicenter Study

View source ↗

Summary

A nationwide multicenter trial evaluating biomarker-integrated digital guidance for the early detection of dementia, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dementia

Snippet

Sponsor: Xuanwu Hospital, Beijing | Conditions: Dementia | Status: RECRUITING